of HUVEC t o surfaces coated with subendothelial extracellular matrix or its components. The synthetic peptide analog of HHLGGAKQAGDV, which is homologous t o the y-chain of human fibrinogen sequence 400-411, did not cause any measurable effect on the integrity of HUVEC monolayers (detachment and attachment). "Hybrid" peptides bearing salient features of both sequences, ie, Ala-Lys-Gln-Arg-GlyAsp-Phe (AKQRGDF) and Lys-Gln-Arg-Gly-Asp-Phe (KQRGDF), had an attenuated effect on the detachment of HUVEC from extracellular matrix. Thus, the integrity of the human endothelial cell monolayer anchored t o the extracellular matrix, as measured in detachment and attachment assays, is disturbed by peptides containing RGD sequence whereas the synthetic peptide His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-GlyAsp-Val (HHLGGAKQAGDV) is nonreactive.
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Asp (RGD), the cell adhesion site in fibronectin described originally by Pierschbacher and Ruoslahti," which is also present in fibrinogen,*O vWf,*' vitronectin,22 laminin? thrombospondin; and type VI collagen. 24 Human fibrinogen contains not only two RGD sequences in the a-chain but also the sequence His-His-Leu-Gly-Gly-Ala-Lys-Gln-AlaGly-Asp-Val (HHLGGAKQAGDV) in the y-chain (y 400-411) identified as the platelet receptor recognition domain." This sequence is not present in other known adhesive proteins although the y 400-411 peptide analogs inhibit the binding of radiolabeled vWf and fibronectin to platelet GPIIb-IIIa.26~27 The reactivity of y 400-411 peptide toward endothelial vitronectin receptor, evaluated in fluid or solid phase ligand binding assays, gave conflicting reSUltS.28~2y
Characterization of the recognition specificity of vascular EC integrins has been studied using receptor-specific antiand synthetic peptide analogs of RGD-containing domain^^','^ in attachment and detachment assays in vitro. Similarly, recognition specificity of vascular EC to specific matrix macromolecules has been analyzed using immunologic techniques with receptor-specific antibodies. 2, 36 The development of synthetic peptide analogs of adhesive proteins as potential blockers of platelet GPIIb-IIIa in vitro and in vivo25337-3y raised the obvious question of whether they are selective toward platelet receptors or do they also derange endothelial integrins. The receptors belonging to the PI and p3 integrin families and expressed on human EC interact with multiple adhesion molecules in the subendothelial extracellular matrix.' Hence, each peptide requires a careful analysis in an assay that evaluates the adhesive function of these endothelial receptors cumulatively toward "native" extracellular matrix and individually toward its component adhesive proteins. The assays measuring EC detachment from and attachment to "complete" subendothelial extracellular matrix, or its components, fulfill this objective. Therefore, we used these assays to study synthetic peptide analogs encompassing the cell binding domains of fibronectin (Gly-Arg-Gly-Asp-Ser-Pro ), y-chain of human fibrinogen (HHLG-GAKQAGDV), and "hybrid" peptides (Ala-Lys-Gln-ArgGly-Asp-Phe [AKQRGDF and KQRGDF]). The latter encompass sequences analogous to receptor recognition domains on a-and y-chains of human fibrinogen?' The rationale for their design was to enhance inhibitory potency of synthetic peptides toward platelet GPIIb-IIIa while retaining selectivity toward platelets.
MATERIALS AND METHODS

Culture of EC.
Human umbilical vein EC (HUVEC) were isolated from several umbilical cords," pooled together, and grown in medium consisting of Medium 199 (Flow Laboratories, Inc, McLean, VA) containing 20% fetal calf serum (FCS; Flow Laboratories), 20 &mL EC growth factor*' and 90 pg/mL heparin (Sigma Chemical Co, St Louis, MO)42 in gelatin-coated tissue culture flasks (Corning Glass Works, Corning, NY). These cells were used between passages 2 through 4 and stained positively for vWf by indirect immunofluorescence. Bovine aortic EC (BAEC) were isolated and cultured as previously de~cribed.4~
Peptides were synthesized by solid-phase methods" with a Biosearch 9500 peptide synthesizer (San Raphael, CA) as previously de~cribed.~' Peptides were cleaved from the resin with H F and purified by using liquid chromatography and high performance liquid chromatography (HPLC) according to the procedures described by Kloczewiak et a1.25.39 Amino acid composition was determined on a Beckman automated analyzer after hydrolysis of the peptide sample at 150°C for 50 minutes with 6 N HCI (Ultrex; Baker Chemical, Phillipsburg, NJ). The amino acid sequencing of isolated peptides was done in an Applied Bioscience automated gas-phase sequencer (Foster City, CA).46 Furthermore, each peptide was analyzed by a negative ion fast atom bombardment (FAB) mass spectroscopy as described*' using a VG ZAB-HF mass spectrometer fitted with a saddle-field FAB gun. The ions were formed by FAB with 8 KeV xenon atoms at a 1-mA discharge current. The ion accelerating voltage was 8 keV. Before use, the peptides were dissolved at 5 mmol/L concentration in Medium 199, pH 7.35.
Human fibrinogen was purified from commercial preparations of Kabi fibrinogen as previously described.26 Human fibronectin was purchased from Calbiochem-Behring Diagnostics (San Diego, CA). Human vitronectin was a gift of Dr Perumal Thiagarajan (University of Washington, Seattle, WA)'* and was also purified from human plasma using the method of Dahlback and P o d a~k .~~ Human vWf was purified from cryoprecipitate as described previously26 with a ristocetin cofactor activity of 500 U/mg of vWf (1 U equals that measured in 1 mL of normal pooled plasma). Protein concentrations were determined by the method of Bradford" using bovine serum albumin (BSA) as a standard. HUVEC (7.5 x 104/well) were seeded in a gelatin-coated 48-well plate (Costar, Cambridge, MA) in 0.5 mL of complete HUVEC media per well and grown to confluence for 2 daysM The cells were then washed twice with serum-free Medium 199 and the various peptides were added in serum-free Medium 199. At the end of 4 hours of incubation at 37T, the cells were rinsed three times with serum-free Medium 199 to remove any nonadherent cells. Photomicrographs were taken using a Zeiss inverted-phase microscope. The negatives were projected through a Kodak Ectagraphic slide projector (Eastman Kodak Co, Rochester, NY) onto a 8.5 in x 11 in paper using a Buhl Optical lens (VFL Peptide synthesis andpurification.
Adhesivepruteins.
Celldetachment assay.
2.4 in-3.6 in; Buhl Optical, Pittsburgh, PA). The projected cell-free areas were traced on the paper with a pen. The percentage of cell-free areas was determined by comparing the weight of the cut-out areas of the projected paper with the total area of cell growth. The interobserver variability of determining cell-free area using this method among three participants was less than 6%.
Extracellular matrix was prepared as described previously'0.5' from BAEC that were confluent for 2 weeks in a 48-well plate. One hundred microliters of human fibronectin and human vitronectin were incubated for 2 hours at room temperature at 5 &mL in 96-well flat-bottom plate (Becton Dickinson Labware, Oxnard, CA). One hundred microliters of human vWf and fibrinogen were incubated for 6 hours at room temperature at 50 pg/mL. At the end of the incubation period 50 pL of 1.0% BSA that had been denatured at 80°C for 3 minutes was added and the plate was incubated for another hour at room temperature. The wells were then washed with phosphate-buffered saline (PBS), pH 7.35, to remove any nonabsorbed protein. 
RESULTS
Contrasting efect of RGD-containing peptides and y-chain peptide on detachment of H W E C from extracellular matrix.
The functional effect of RGD-containing peptide and y 400-411 peptide analogs on confluent monolayer of HU-VEC was studied by testing the peptide's ability to disorganize the monolayer, ie, causing rounding up of cells (inhibition of cell-cell interaction and spreading), release of cells into the media (total cell detachment). Early in our studies we realized that measuring the radioactivity released into the media of metabolically 35S-labeled HUVEC monolayer as previously described3' only measured the 'total' cell detachment. Cells that were 'rounding' up (inhibition of cell-cell contact and spreading with maintained cell-matrix interaction) or cells that resembled 'curled-up' edges (inhibition of cell-matrix interaction with preservation of cellcell contact) were not accounted for by measuring the radioactivity of released cells into the media. Therefore, we decided to measure the cell-free area as the index of 'detaching effect' of peptides on the monolayer.
As seen in Fig 1, peptide y 400-411 at 1.5 mmol/L concentration (Fig 1B) did not cause any significant detachment of EC as compared with control ( Fig 1A) . On the other hand, GRGDSP (Fig IC) at 1.5 mmol/L concentration showed significant cell detaching effect. AKQRGDF, a hybrid peptide analog of y-chain sequence and a-chain For personal use only. on October 3, 2017. by guest www.bloodjournal.org From sequence of fibrinogen, had an intermediate effect ( Fig  1D) .
As demonstrated in Fig 2, the peptide analogs containing RGD motif caused detachment of EC in a concentrationdependent manner. y 400-411 peptide analog up to the 1.5 mmol/L concentration tested did not cause any significant detachment reflected by the cell-free area as compared with control wells without peptides (P = .91). Therefore, there was a significant difference of cell-free area between y 400-411 and GRGDSP peptide analogs at 0.5, 1.0, and 1.5 mmol/L concentration tested (P ranging from .0001 to .004) and all other RGD-containing peptide analogs at 1.0 and 1.5 mmol/L concentration tested (P ranging from .001 to .05). There was no significant difference in the cell-free area among all the different RGD-containing peptide analogs. The notable exception was "hybrid" peptide AKQRGDF, which showed significantly less cell detaching effect at 1.0 and 1.5 mmol/L concentration tested as compared with GRGDSP (P ranging from .006 to .008).
Effect of peptide analogs on attachment of H W E C to the components of extracellular matrix. Peptide y 400-411 at 1.5 mmol/L concentration tested did not inhibit HUVEC attachment to fibronectin-, vitronectin-, and fibrinogencoated plastic surfaces as compared with control (Fig 3) . In contrast, GRGDSP peptide analog at 1.5 mmol/L concentration caused inhibition of cell spreading on fibronectincoated dishes, as well as inhibition of cell spreading and cell attachment on vitronectin-and fibrinogen-coated dishes. Routinely, 50% to 60% of the total cells plated have attached to fibronectin-or vitronectin-coated plastic dishes at the end of the 1 hour of incubation. However, only 15% to 25% of the total cells plated have attached to vWf-or fibrinogen-coated plastic dishes during the 1 hour of incubation despite the use of higher concentration and longer incubation time for coating vWf and fibrinogen to plastic dishes.
As seen in Table 1 , y 400-411 up to 1.5 mmol/L concentration tested did not inhibit cell attachment and spreading to fibronectin-, vitronectin-, vWf-, and fibrinogencoated dishes as compared with control wells with no peptide added. Cell attachment to denatured BSA was less than 10% of the control wells. GRGDSP and AKQRGDF experiments performed by Gaynor et al? who observed circulating EC following injection of endotoxic lipopolysaccharide. Stewart et alSr observed endothelial desquamation in response to surgical trauma even at distant sites. Therefore, it is of great interest to establish the specific role of EC receptors in maintaining their links with subendothelial matrix. The bulk of evidence on the adhesive function of receptors on EC involved in cell-cell and cell-matrix interaccaused a significant decrease of cell spreading on fibronectincoated surface only at 1.5 mmol/L concentration tested (P ranging from .01 to .015), although there was no inhibition of cell attachment noted. GRGDSP and AKQRGDF caused significant inhibition of cell attachment and spreading on vitronectin-, vWf-, and fibrinogen-coated surfaces at 0.5 and 1.5 mmol/L concentration (P ranging from .0006 to .009). GRGDSP and AKQRGDF also caused significant inhibition of cell attachment to and spreading on "native" matrix deposited by BAEC (P ranging from .004 to .008). y 400-411 did not show any significant effect on cell attachment and spreading on "native" matrix formed by BAEC as compared with control wells. DISCUSSION tion comes from in vitro studies involving attachment and detachment assays" using receptor-specific or synthetic peptide analogs of cell adhesion domains of matrix macromolecules.'".'' Application of a polyclonal extracellular matrix receptor antibody (GP-140) that disrupts adhesion of the HUVEC monolayer led to the identification of four cell-matrix receptors on EC in the integrin superfamily (a fibronectin receptor, aspI; a collagen receptor, a,p,; a multifunctional receptor that binds fibronectin, collagen, and laminin, a3& and a vitronectin receptor, CX&~). ' Vitronectin receptor (a&), sharing the p3 subunit with the platelet fibrinogen receptor (allb& or GPIIb-IIIa complex), recognizes a similar repertoire of adhesive proteins containing the RGD sequence.'"'' A unique platelet binding domain in the carboxy-EC are firmly anchored to the vascular wall and there is a paucity of reports indicating "spontaneous" detachment of EC in vivo. Induced detachment was suggested from terminal end of the y-chain of human fibrinogen, encompassing residues 400-41 1 (HHLGGAKQAGDV), is not present in any other ligands for integrins.2s,3x The fact that y 400-411 peptide analog did not detach the HUVEC monolayer from its matrix indicates that the endothelial vitronectin receptor a-subunit (g) differs in recognition specificity from platelet GPIIb (a,,,). This result obtained in EC detachment assay is concordant with a lack of reactivity of the endothelial vitronectin receptor toward the peptide y 400-41 1, observed in a solid-phase a~say.'~ However, it is at variance from the observation made by Tranqui et a1 in regard to the fluid-phase binding of fibrinogen to human EC in suspension.z8 Different experimental conditions (3 hours of binding of fibrinogen to detached EC) might contribute to these discrepant results. However, both receptors are inhibited by a panel of RGD-containing peptides corresponding to relevant sequences in fibronectin, human fibrinogen a-chain, vWf, and vitronectin. These results confirmed and extended previous s t u d i e~.~~~' "~~ We used peptide concentrations up to 1.5 mmol/L according to the initial study of Hayman et aI3' on the RGD-containing peptides. This concentration was 43 to 750 times higher than the IC,, of RGD-containing peptides in inhibiting fibrinogen binding to platelets in ~i t r o .~~.~' The lesser effect of RGD peptides on detachment of EC in our study as compared with Hayman et aI3' may be explained by the culture conditions, ie, confluent versus semiconfluent culture, 2-day growth versus 1-day growth, gelatin-versus fibronectin-coated plastic dishes, and different concentrations of growth factors and heparin.
"Hybrid" peptides were constructed previously by us to encompass salient structural features of the sequences from the y-and a-chain of human fibrinogen to maintain selectivity while increasing the inhibitory potency toward platelets.38 They showed less effect on detachment of HUVEC than other members of the RGD peptide panel tested. Thus, their enhanced inhibitory potency toward the platelet receptor for fibrinogen is accompanied by decreased reactivity toward endothelial receptor for vitronectin. Interestingly, the seven amino acid hybrid peptide (AKQRGDF) rather than the six amino acid hybrid peptide (KQRGDF) had significantly attenuated effect on detachment of HUVEC as compared with GRGDSP at 1.0 and 1.5 mmol/L concentration tested. The influence on cell attachment of flanking residues surrounding the sequence RGD has been noted previously.'y~45~s7 Whether longer RGD-containing sequences from the various RGD-containing matrix macromolecules may significantly modulate the detaching effect of their peptide analogs on confluent HUVEC monolayer, as compared with the shorter peptides tested in this report, remains to be determined. The composition of phospholipid bilayers influenced the ligand reactivity of the vitronectin receptor."
The disruption of EC monolayers in vitro by antireceptor antibodies and by synthetic peptides containing the RGD motifs constitutes only one aspect of interactions of HU-VEC with extracellular matrix. Importantly, the initial seeding of matrix by EC is also mediated by their adhesive receptors. Seeding or attachment proceeds in at least two stages: initial contact of rounded-up cells and their subsequent spreading to allow optimal cell-matrix interactions.' In this respect, the synthetic peptides containing sequence from the carboy-terminal segment of the y-chain (y 400-411) remained neutral and did not interfere with attachment to components of extracellular matrix studied shown herein, the potential deleterious effect of the infused RGD-containing peptides on structural and functional integrity of the vascular EC, and on healing of zones of vascular injury in vivo, warrants serious consideration.
In summary, y 400-411 peptide analog seems unreactive towards integrins involved in anchoring of cultured human EC to extracellular matrix in vitro as determined in the detachment and attachment assays used in this study.
Hence, while the sequence represented by peptide y 400-411 is reactive toward p3 integrins on platelets, it is nonreactive toward related integrins on EC. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
